Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Race against time: can early angioplasty save diabetic feet?

NCT ID NCT06124586

Symptom relief Sponsor: Heinrich-Heine University, Duesseldorf Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether repairing blocked leg blood vessels within 48 hours helps heal foot ulcers in people with type 2 diabetes faster than waiting for a scheduled procedure. About 200 adults with diabetic foot sores will be randomly assigned to early or standard treatment. Researchers will track wound healing using a 3D camera and AI, and monitor heart and limb complications for one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

Nov 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * volunteer adults * written informed consent * presence of known manifest T2D and fulfilment of the following criteria: * HbA1c \< 10% * presence of pAVD with fulfillment of the following criteria: * PAD Stage After Fontaine IV (foot ulcer) * Presence of foot ulcer with fulfillment of the following criteria: * Foot ulceration without indication for emergency surgical care from stage Wagner 1. * Age \>18 years Exclusion Criteria: * Acute leg ischemia (sudden onset, sensorimotor deficits, pale extremity, pain, loss of pulse, and shock). * Type 1 diabetes mellitus (GADA, ICA, IA-2A, ZnT8A positive). * Minors or subjects incapable of giving consent * Pregnant or breastfeeding women * Treatment with certain drugs (immunosuppressive therapy, * Immunomodulators, chemotherapy, antibiotic therapy \< 2 weeks before * intervention) * Diseases of the pancreas * Severe neurological or psychiatric disease * Known presence of malignant tumor disease within the past 5 years * Participation in other interventional trials and receipt of investigational medication within the last 30 days * Blood or plasma donation within the last 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anemia diabetes mellitus Diabetic Foot diabetic neuropathy diabetic polyneuropathy diabetic retinopathy Foot Ulcer peripheral arterial disease type 2 diabetes mellitus ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anemia Diabetes mellitus Diabetic foot Diabetic neuropathies Diabetic polyneuropathy Diabetic retinopathy Peripheral arterial disease Ulcer foot Ulcer ischemic

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular Medicine

    RECRUITING

    Düsseldorf, 40225, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.